Fig. 1From: Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessmentClinical trial flow chart. Structure and patient enrollment in the trialBack to article page